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Breanna Wentz*, Jaclyn Einspahr*, Michael Godsey Ph.D
Math and Science Department, Concordia University, Portland, OR 97211. *Authors contributed equally to this work.
Abstract / Introduction
Deoxynucleoside analogues are prodrugs that
can function as inhibitors of both viral and
cellular DNA replication processes. They are
important in anti-cancer therapy because they
hinder DNA synthesis and cellular mitosis.
Within the cell, deoxyribonucleotides are
synthesized using the salvage pathways by
converting the unphosphorylated nucleosides
to their mono, di- and tri-phosphate forms
using a phosphoryl donor: ATP or UTP. Human
deoxycytidine kinase (dCK) is the first and
rate-limiting enzyme in this process. The dCK
protein uses nucleotide triphosphates to
phosphorylate several clinically important
nucleoside analogue prodrugs in addition to its
natural substrates. The preferred physiological
phosphoryl donor for dCK is UTP although it is
less prevalent in the human body than ATP.
Our objective is to improve the understanding
of the phosphate-donor binding loop of dCK by
kinetic analysis of a series of mutants of
Asp241 and Phe242. These mutants were
designed in an attempt to improve the activity
of dCK with phosphate donors. Results show
several mutants with improved kinetics and
some with an ATP donor preference over UTP.

Results
Figure 1:

Table 1: Kinetic Analysis of dCK mutants

Gel indicates the presence of the mutant dCK
proteins D241A and D241E/F242L after
purification. Bands appeared at the expected
protein size of 31 kilodaltons as indicated by
the ladder. This showed that our purified
protein was in present in the samples
collected. All other samples produced similar
results.
Figure 2:
D241N/F242L with ATP

D241Q with UTP

Materials and Methods
Mutated histidine-tagged dCK proteins were
grown in E.coli and purified by immobilized
metal affinity chromatography using Co++
resin. Purified proteins were analyzed by
SDS-PAGE gel electrophoresis. Protein was
>95% pure. Kinetic assays were performed in
assay buffer (100mM Tris pH 7.5, 200mM KCl,
5mM MgCl2, 80µM Phosphoenolpyruvate,
400µM NADH, and 250µM cytosine-β-Darabinofuranoside (araC)). Helper enzymes
lactate dehydrogenase and pyruvate kinase
were added to reaction. Phosphoryl donor
(ATP or UTP) was added in concentration
ranging from 1µM to 200µM. Finally, 0.4µM
dCK was added and NADH oxidation was
monitored spectrophometrically by A340
decrease over time (Agarwal)

Results

Michaelis- Menten Equation

kcat are in sec-1, KM are in µM, Vmax are in
µM/sec, and kcat/KM are in µM-1sec-1. Vmax and
KM values are determined by curve fitting to the
M-M equation. KM is defined as the substrate
concentration required to reach ½ Vmax. Lower
KM indicates less substrate is required to
approach maximum velocity. A higher kcat/KM
value indicates a more efficient enzyme.

Conclusions
D241N with ATP

D241A with ATP

Michaelis-Menten Kinetics: Initial velocity (Vo)
calculated using NADH absorbance decrease
vs. concentration of the phosphate donor
used, either ATP or UTP. Phosphate acceptor
araC was 250µM in all reactions. All other
experiments produced similar curves.

Our results showed that mutating the dCK
residues will open up the active donor site to
make it more accessible to bind ATP and UTP
resulting in more phosphate donor flexibility.
Significantly we found an increased rate for
mutants D241N, D2412N/F242L, and F242L.
This research has the potential to progress
anti-cancer therapy as a more efficient form of
dCK can act as an inhibitor of both viral and
cellular DNA replication. Kinetic assays with
other nucleoside analogues will be performed
to extend the results of our research.

Results
Overall Kinetic Assay Equation:

NADH absorbs light at 340nm, while NAD+
does not. Based on the above reactions, the
ratio
between
NADH
oxidation
and
phosphorylation by dCK is 1:1. Pyruvate
kinase and Lactate dehydrogenase are orders
of magnitude faster than dCK. Therefore, by
measuring NADH oxidation we can measure
phosporylation by dCK. (Agarwal) [NADH] is
determined by absorption: A340=ℓ x ε x
[NADH], where A is the absorbance at 340nm,
ℓ is the path length (1cm) and ε is the
absorption coefficient of NADH=6200M-1cm-1.
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